hydralazine and azomycin

hydralazine has been researched along with azomycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboagye, EO; Graham, MA; Griffiths, JR; Horsman, MR; Kelson, AB; Lewis, AD; Maxwell, RJ; Tracy, M; Workman, P1
Bailey, KM; Baker, AF; Cornnell, HH; Gillies, RJ; Hart, CP; Ibrahim-Hashim, A; Leos, R; Martinez, GV; Wojtkowiak, JW; Zhang, X1

Other Studies

2 other study(ies) available for hydralazine and azomycin

ArticleYear
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
    Cancer research, 1997, Aug-01, Volume: 57, Issue:15

    Topics: Animals; Carbon Dioxide; Cell Hypoxia; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Female; Fluorine; Hydralazine; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Reproducibility of Results

1997
Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Circulation; Cell Hypoxia; Cell Line, Tumor; Drug Synergism; Female; Humans; Hydralazine; Hydrogen-Ion Concentration; Mice; Nitroimidazoles; Pancreatic Neoplasms; Phosphoramide Mustards; Prodrugs; Tumor Microenvironment; Xenograft Model Antitumor Assays

2014